Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Howard Pai

Population-Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for Up to 5 Oligometastases: SABR-5

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Patient Accessible Electronic Health Records: Exploring Recommendations for Successful Implementation Strategies

Journal of Medical Internet Research
Health Informatics
2008English

Related publications

Imaging Follow-Up After Stereotactic Ablative Radiotherapy (SABR) for Lung Tumors

Journal of Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2012English

MS20.02 the Future of Stereotactic Ablative Radiotherapy (SABR)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.08-17 Paediatric Motion Management Solutions for Particle Therapy Based Thoracic Stereotactic Ablative Body Radiotherapy (SABR)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MTE24.02 Small Lung Tumours: High Risk Lesions and Contraindications to Stereotactic Ablative Body Radiotherapy (SABR)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Immune Correlates of Abscopal Response in a Lead-In Phase II Trial of Neoadjuvant Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

P2.16-15 Toxicities and Survival After Stereotactic Ablative Radiotherapy (SABR) for Centrally Located Lung Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.16-26 Safety of SABR (Stereotactic Ablative Body Radiotherapy) for Central Non-Small Cell Lung Cancers (cNSCLC) With 50 Gray in 5 Fractions (50Gy/5f)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Establishing a Histology-Specific Biologically Effective Dose Threshold for Lung Stereotactic Ablative Radiotherapy (SABR): Is ≥100 Gy10 Enough?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

P3.16-15 Kinetic Energy Distribution for Gated Technique at Lung Ablative Body Radiotherapy (SABR)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy